Previous 10 | Next 10 |
5 Penny Stocks On Robinhood To Watch This Month Investing in penny stock can often prove to be the most rewarding class of stocks for investors. Why? Over the years, these stocks have generated a lot of wealth for investors, quickly. One of the most important things that need to be pointed o...
Gainers: ShiftPixy (NASDAQ: PIXY ) +162% . More news on: ShiftPixy, Inc., Wah Fu Education Group Limited, Verastem, Inc., Stocks on the move, Read more ...
ShiftPixy (NASDAQ: PIXY ) +199% on completing recapitalization . More news on: ShiftPixy, Inc., Applied Therapeutics, Inc., Mechel PAO, Stocks on the move, Read more ...
Verastem (NASDAQ: VSTM ) is up 14% premarket on announcing a global licensing agreement with Chugai Pharmaceutical ( OTCPK:CHGCF ) to obtain worldwide development and commercialization rights for RAF/MEK inhibitor CH5126766 (CKI27) from Chugai currently under development f...
Combination of Defactinib and CH5126766 Shows Promise in Treating KRAS Mutant Solid Tumors in Clinical Trial Clinical Data Presentation and Regulatory Discussions Planned for 1H 2020 Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company f...
Merck's $2.7B bid for ArQule is yet another example of the Big Biopharma's high regard for oral kinase inhibitors for treating cancer. ArQule's lead drug is ARQ 531, an oral inhibitor of Bruton's tyrosine kinase (BTK). More news on: Pfizer Inc., Eli Lilly and Company, AbbVie Inc., Health...
Duvelisib Achieves Overall Response Rate of 62% in Patients with Relapsed or Refractory PTCL with Manageable Safety Profile in Initial Phase of PRIMO Trial Data Presented Support Potential of Duvelisib Across Indications, Lines of Therapy and in Combination Verastem, Inc. (Nasdaq:...
Gainers: ChemoCentryx (NASDAQ: CCXI ) +261% . More news on: ChemoCentryx, Inc., Akerna Corp., Proteostasis Therapeutics, Inc., Stocks on the move, Read more ...
These Penny Stocks Can Be Bought For Under $2.75 Right Now; Will That Be The Case Next Month? Penny stocks tend to fly high and drop hard. It’s the nature of the market. High risk/high reward isn’t for those not capable of managing risk. And if this is you, that’s ok. Bu...
Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced the submission of a Marketing Authorization Application to t...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Sangamo Therapeutics Inc. (SGMO) rose 50.7% to $0.604699 on volume of 90,844,210 shares Selina Hospitality PLC (SLNA) rose 7.7% to $0.028 on volume of 57,431,570 shares NuZee Inc. (NUZE) rose 260.1% to $3.7094 on volume of 53,639,595 ...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock and accompanying warrants to purchase up to 13,333,334 shares of it...
Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock, as well as pre-funded warrants t...